Insulin Therapy Guidelines After Subtotal Pancreatectomy
Introduction to Insulin Regimens
- The American Diabetes Association recommends implementing a basal-bolus insulin regimen for patients after subtotal pancreatectomy, as this approach most faithfully replicates normal pancreatic physiology and improves glycemic control while reducing postoperative complications 1
Immediate Postoperative Management
- Maintain intravenous insulin infusion until blood glucose levels stabilize at ≤10 mmol/L (180 mg/dL) and oral feeding resumes 2, 3
- Target blood glucose range should be maintained between 100-180 mg/dL (5.6-10.0 mmol/L) during the perioperative period 4
- Monitor capillary blood glucose levels every 1-2 hours while the patient is NPO to detect hypoglycemia or hyperglycemia 4
- Administer glucose immediately for blood glucose <3.3 mmol/L (60 mg/dL), even in the absence of symptoms 5
Transition from IV to Subcutaneous Insulin
- Transition to subcutaneous insulin when blood glucose levels have been stable for at least 24 hours, patient has resumed oral feeding, and IV insulin infusion rate is <3 U/h 3
- For the transition protocol, administer long-acting (basal) insulin immediately after stopping IV insulin, and calculate initial dose based on total daily IV insulin requirements 3
Long-term Insulin Management
- Use a basal-bolus regimen consisting of long-acting insulin for basal coverage, ultra-rapid insulin for prandial coverage, and correction doses of ultra-rapid insulin for hyperglycemia 1
- Initial dosing for patients not previously on IV insulin should start with 0.5-1.0 IU/kg/day based on patient weight, divided as 50% basal and 50% prandial insulin 3
Management of Glycemic Emergencies
- For hypoglycemia (<3.3 mmol/L or 60 mg/dL), use oral glucose if patient is conscious, and IV glucose if patient is unconscious or unable to swallow 5
- For severe hyperglycemia (>16.5 mmol/L or 300 mg/dL), check for ketosis in all patients, administer ultra-rapid insulin, and ensure adequate hydration 6